trending Market Intelligence /marketintelligence/en/news-insights/trending/sea0auxy1pr-tcicikyswq2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

CytoDyn raises C$1M via securities offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


CytoDyn raises C$1M via securities offering

CytoDyn Inc. raised about C$1 million through a registered direct offering.

The Canadian developer of HIV treatments issued 1,970,000 shares at 50 Canadian cents each. Each stock will come bundled with a warrant to buy an additional stock for 75 cents apiece.

CytoDyn plans to use net proceeds, expected to be about C$900,000, on clinical trials for its lead product candidate and general corporate purposes.

Paulson Investment Co. LLC acted as placement agent for the offering.